Literature DB >> 3087771

Malic enzyme levels are increased by the activation of NADPH-consuming pathways: detoxification processes.

A Ayala, M F-Lobato, A Machado.   

Abstract

The administration to rats of either t-butyl hydroperoxide or phenobarbital, compounds that are metabolized through detoxification processes, produces an increase in specific activity of the NADPH-consuming enzymes, glutathione reductase and NADPH-cytochrome c reductase. These compounds also produce a very significant increase in the specific activity of malic enzyme. Immunoprecipitation with a specific antibody for malic enzyme indicates that specific activity changes are the result of corresponding changes in the amounts of enzyme protein present. The administration of 1,3-bis(chloroethyl(-1-nitrosourea (a glutathione reductase inhibitor) together with t-butyl hydroperoxide abolishes any stimulation of malic enzyme activity. These results indicate that an increase in NADPH consumption induces the synthesis of malic enzyme. Alternatively, a protection of enzyme degradation cannot be rigorously excluded.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3087771     DOI: 10.1016/0014-5793(86)80657-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Possible involvement of NADPH requirement in regulation of glucose-6-phosphate and 6-phosphogluconate dehydrogenase levels in rat liver.

Authors:  A Ayala; I Fabregat; A Machado
Journal:  Mol Cell Biochem       Date:  1990-06-25       Impact factor: 3.396

2.  Characterization of two genes involved in chromate resistance in a Cr(VI)-hyper-resistant bacterium.

Authors:  Francesca Decorosi; Enrico Tatti; Annalisa Mini; Luciana Giovannetti; Carlo Viti
Journal:  Extremophiles       Date:  2009-09-19       Impact factor: 2.395

3.  Biophysical characterization of the dimer and tetramer interface interactions of the human cytosolic malic enzyme.

Authors:  Sujithkumar Murugan; Hui-Chih Hung
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.